United Health Products (UEEC)
(Delayed Data from OTC)
$0.17 USD
0.00 (2.36%)
Updated Aug 27, 2024 03:53 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for United Health Products, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 2 | 3 | 30 | 15 | 6 |
Income After Depreciation & Amortization | -2 | -3 | -30 | -15 | -6 |
Non-Operating Income | 0 | 1 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 1 | 1 | 1 |
Pretax Income | -3 | -2 | -31 | -16 | -7 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -3 | -2 | -31 | -16 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -3 | -2 | -31 | -16 | -7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -2 | -3 | -29 | -14 | -6 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -2 | -3 | -30 | -15 | -6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 239.08 | 229.72 | 225.74 | 183.76 | 175.88 |
Diluted EPS Before Non-Recurring Items | -0.01 | -0.01 | -0.14 | -0.09 | -0.04 |
Diluted Net EPS (GAAP) | -0.01 | -0.01 | -0.14 | -0.09 | -0.04 |
Fiscal Year end for United Health Products, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.41 | 0.43 | 0.44 | 0.45 | 0.48 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.41 | -0.43 | -0.44 | -0.45 | -0.48 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
Interest Expense | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
Pretax Income | -0.43 | -0.45 | -0.47 | -0.49 | -0.52 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.43 | -0.45 | -0.47 | -0.49 | -0.52 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.43 | -0.45 | -0.47 | -0.49 | -0.52 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 247.72 | 245.75 | 245.51 | 241.49 | 238.27 |
Diluted EPS Before Non-Recurring Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Diluted Net EPS (GAAP) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |